HCR presenting at Clinical Trials in Oncology Congress

Wolfgang Hamm, M.D., Ph.D., Senior Clinical Research Physician at HCR, will be giving a presentation on the occasion of the 2nd Annual Congress "Clinical Trials in Oncology", entitled:

"Establishing endpoints for your cancer clinical trial to get the most valuable trial outcome".

The congress will be held on the 1st & 2nd December 2009 at the Hotel Hilton Munich City. During his talk, Dr. Hamm will outline the state-of-the-art of neoadjuvant chemotherapy for invasive breast cancers, present the pivotal phase III studies and ongoing clinical trials in the neoadjuvant setting and put this current knowledge into future perspectives using in vivo chemosensitivity testing as platform to speed up drug development, especially the development of molecularly targeted therapies.
Harrison Clinical Research is a silver sponsor of this event and our representatives will be delighted to greet you at the congress at our booth and do please drop by and discuss your oncology requirements with Dr.Hamm and his colleagues.

Official programme of the congress

ContactIf you would like to contact Dr. Hamm, in advance of the congress, please press the contact button.